Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuxiang Lin

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
International Journal of Molecular Sciences|September 14, 2024
SlHB8 Is a Novel Factor in Enhancing Cold Resistance in Tomato Anthers by Modulating Tapetal Cell DeathHongling Guan, Canye Yu, Zaohai Zeng, et al.
Journal of Cancer Research and Clinical Oncology|June 24, 2024
Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in ChinaJing Li, Peng He, Qindong Cai, et al.
NPJ Genomic Medicine|July 2, 2025
Clinical TP53 genetic testing is recommended for HER2-positive breast cancer patients aged 35 or youngerJing Li, Lili Chen, Xuhui Chen, et al.
Breast Cancer Research and Treatment|January 5, 2025
Frequency of somatic and germline variants of predisposition genes in young Chinese women with breast cancerYuchun Xu, Qindong Cai, Jing Li, et al.
Plant Science : an International Journal of Experimental Plant Biology|July 16, 2023
The SlARF4-SlHB8 regulatory module mediates leaf rolling in tomatoXiaojuan Liu, Yuxiang Lin, Caiyu Wu, et al.
Journal of Translational Medicine|January 7, 2022
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1Yuxiang Lin, Jie Zhang, Yan Li, et al.
Gigascience|July 14, 2020
Assessment of fecal DNA extraction protocols for metagenomic studiesFangming Yang, Jihua Sun, Huainian Luo, et al.
Cancer|January 21, 2026
The evolution and prognostic impact of HER2-low, HER2-ultralow, and HER2-null status in HER2-negative early breast cancer: A pre- to post-neoadjuvant chemotherapy studyYibin Qiu, Long Wu, Weifeng Cai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 1, 2024
Ccl2-Induced Regulatory T Cells Balance Inflammation Through Macrophage Polarization During Liver ReconstitutionRui Wang, Qing Liang, Qian Zhang, et al.
Annals of Translational Medicine|March 14, 2022
YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m<sup>6</sup>A-dependent mannerYuxiang Lin, Xuan Jin, Qian Nie, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|September 14, 2024
SlHB8 Is a Novel Factor in Enhancing Cold Resistance in Tomato Anthers by Modulating Tapetal Cell DeathHongling Guan, Canye Yu, Zaohai Zeng, et al.
Journal of Cancer Research and Clinical Oncology|June 24, 2024
Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in ChinaJing Li, Peng He, Qindong Cai, et al.
NPJ Genomic Medicine|July 2, 2025
Clinical TP53 genetic testing is recommended for HER2-positive breast cancer patients aged 35 or youngerJing Li, Lili Chen, Xuhui Chen, et al.
Breast Cancer Research and Treatment|January 5, 2025
Frequency of somatic and germline variants of predisposition genes in young Chinese women with breast cancerYuchun Xu, Qindong Cai, Jing Li, et al.
Plant Science : an International Journal of Experimental Plant Biology|July 16, 2023
The SlARF4-SlHB8 regulatory module mediates leaf rolling in tomatoXiaojuan Liu, Yuxiang Lin, Caiyu Wu, et al.
Journal of Translational Medicine|January 7, 2022
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1Yuxiang Lin, Jie Zhang, Yan Li, et al.
Gigascience|July 14, 2020
Assessment of fecal DNA extraction protocols for metagenomic studiesFangming Yang, Jihua Sun, Huainian Luo, et al.
Cancer|January 21, 2026
The evolution and prognostic impact of HER2-low, HER2-ultralow, and HER2-null status in HER2-negative early breast cancer: A pre- to post-neoadjuvant chemotherapy studyYibin Qiu, Long Wu, Weifeng Cai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 1, 2024
Ccl2-Induced Regulatory T Cells Balance Inflammation Through Macrophage Polarization During Liver ReconstitutionRui Wang, Qing Liang, Qian Zhang, et al.
Annals of Translational Medicine|March 14, 2022
YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m<sup>6</sup>A-dependent mannerYuxiang Lin, Xuan Jin, Qian Nie, et al.
Pageof 13